By identifying Fam20c as a key molecular switch in adipocyte dysfunction, our findings provide insights into the mechanisms driving obesity-related metabolic diseases and offer potential therapeutic avenues for preventing or treating T2D. This evidence concerns the gene FAM20C and Other metabolic disease.